The device, developed by magAssist, is an interventional ventricular assistance device.
The FDA designated magAssist’s NyokAssist as a breakthrough device.
In a press release from magAssist, the company announced the decision. The designation identifies the NyokAssist as a novel device that has the potential to save lives and treat debilitating diseases.
The NyokAssist is a ventricular assistance device that features a foldable catheter pump. It has been designed to be quickly and easily inserted or removed from the human body. It also includes an external motor which reduces the risk of overheating and ensure sufficient blood flow.
FDA issues de novo clearance for SonoMotion’s Stone Clear device, for kidney stone treatment
Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.